Literature DB >> 33641454

FDA Safety Warning on the Cardiac Effects of Lamotrigine: An Advisory From the Ad Hoc ILAE/AES Task Force.

Jacqueline A French1,2, Emilio Perucca3, Josemir W Sander4,5,6, Lennart Bergfeldt7,8, Michel Baulac9, David S Auerbach10, Mark Keezer6,11, Roland D Thijs5,6,12, Orrin Devinsky1,2, David G Vossler13, Timothy E Welty14.   

Abstract

Entities:  

Year:  2021        PMID： 33641454     DOI： 10.1177/1535759721996344

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  5 in total

1.  QT prolongation in patients with index evaluation for seizure or epilepsy is predictive of all-cause mortality.

Authors:  C Anwar A Chahal; Joseph A Gottwald; Erik K St Louis; Jiang Xie; Peter A Brady; Rabe E Alhurani; Paul Timm; Prabin Thapa; Jay Mandrekar; Elson L So; Janet E Olson; Michael J Ackerman; Virend K Somers
Journal:  Heart Rhythm       Date:  2021-11-11       Impact factor: 6.343

2.  Stroke and Ischemic Heart Disease With Enzyme-inducing Antiseizure Medications: Time to Change Prescribing Habits.

Authors:  David G Vossler
Journal:  Epilepsy Curr       Date:  2022-01-12       Impact factor: 7.500

3.  Evaluation of Cardiovascular Concerns of Intravenous Lacosamide Therapy in Epilepsy Patients.

Authors:  Yan-Ting Lu; Chih-Hsiang Lin; Chen-Jui Ho; Che-Wei Hsu; Meng-Han Tsai
Journal:  Front Neurol       Date:  2022-07-04       Impact factor: 4.086

Review 4.  The brain-heart interaction in epilepsy: implications for diagnosis, therapy, and SUDEP prevention.

Authors:  Giorgio Costagliola; Alessandro Orsini; Monica Coll; Ramon Brugada; Pasquale Parisi; Pasquale Striano
Journal:  Ann Clin Transl Neurol       Date:  2021-05-28       Impact factor: 4.511

Review 5.  Neuropharmacology of Antiseizure Drugs.

Authors:  Tahir Hakami
Journal:  Neuropsychopharmacol Rep       Date:  2021-07-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.